ALFA Finder
20:01 IST
BSE
Results Update
Evonile Pharma Results Update
Evonile Pharma reported Q2 FY27 revenue of ₹56.1 crore and an EBITDA loss of ₹31.8 crore. H1 FY27 profit after tax was a loss of ₹45.3 crore.
Evonile Pharma Ltd
Evonile Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹1,562.55
- Market cap
- ₹5,064 Cr
- Revenue (annual)
- ₹354.3 Cr
- Net profit (annual)
- ₹93.18 Cr
- P/E (TTM)
- -1269.1×Sector 43.8×
- Promoter holding
- 70.68%+0.00% QoQ
- FII holding
- 1.21%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 6Financial Results 5Annual General Meeting 5Earnings Call 4Open Offer 3Business Update 3Board Meeting Outcome 3Board Meeting Date 3Promoter Selling (Off-Market) 2Management Change 2Fund Raise 2Capital Structure Change 2Results Update 1Promoter Reclassification 1Promoter Buying (Off-Market) 1Partnership 1Merger & Restructuring 1Debt & Borrowing 1Credit Rating 1Acquisition 1
Time
1 announcement with these filters